Marwah Abdalla1, Elvis A Akwo2, David A Bluemke3, João A C Lima4, Daichi Shimbo5, Mathew S Maurer5, Alain G Bertoni6. 1. Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY, United States of America. Electronic address: ma2947@cumc.columbia.edu. 2. Department of Medicine, Division of Epidemiology, Vanderbilt University, Nashville, TN, United States of America. 3. Department of Radiology, School of Medicine and Public Health University of Wisconsin, Madison, WI, United States of America. 4. Department of Medicine, Division of Cardiology, School of Medicine, Johns Hopkins University, Baltimore, MD, United States of America. 5. Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY, United States of America. 6. Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Abstract
BACKGROUND: The myocardial contraction fraction (MCF: stroke volume to myocardial volume) is a volumetric measure of left ventricular myocardial shortening. We examined the relationship of MCF, measured by cardiac magnetic resonance imaging (cMRI), to incident cardiovascular (CV) events within the Multi-Ethnic Study of Atherosclerosis (MESA). METHODS: Participants (n = 5000, aged 45-84 years) underwent cMRI. PRIMARY OUTCOME: CVD events (myocardial infarction, resuscitated cardiac arrest, stroke, coronary heart disease: CHD death, and stroke death). SECONDARY OUTCOMES: CHD and heart failure (HF) events. Cox proportional hazards regression was used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) for outcomes. RESULTS: There were 299 incident CVD, 188 CHD, and 151 HF events over 10.2 years. The lowest MCF quartile was associated with an increased risk for incident CVD [HR 2.42, CI: 1.58-3.72], CHD [HR 2.32, CI: 1.36-3.96] and HF events [HR 1.99, CI: 1.15-3.44]. In a model adjusted for demographics, CV risk factors, antihypertensive and lipid-lowering medication use, each standard deviation decrease in MCF was associated with incident CVD [HR 1.42, CI: 1.23-1.64], CHD [HR 1.40, CI: 1.17-1.67] and HF [HR 1.58, CI: 1.30-1.94]. In a subgroup analysis of participants with preserved ejection fraction and without left ventricular hypertrophy, the lowest MCF quartile and each standard deviation decrease in MCF was also associated with an increased risk for incident CVD in fully-adjusted analyses. CONCLUSIONS: MCF is a novel measure that can be measured using cMRI. In this multi-ethnic cohort, MCF is a measure that can be used to predict incident CVD events.
BACKGROUND: The myocardial contraction fraction (MCF: stroke volume to myocardial volume) is a volumetric measure of left ventricular myocardial shortening. We examined the relationship of MCF, measured by cardiac magnetic resonance imaging (cMRI), to incident cardiovascular (CV) events within the Multi-Ethnic Study of Atherosclerosis (MESA). METHODS: Participants (n = 5000, aged 45-84 years) underwent cMRI. PRIMARY OUTCOME: CVD events (myocardial infarction, resuscitated cardiac arrest, stroke, coronary heart disease: CHD death, and stroke death). SECONDARY OUTCOMES: CHD and heart failure (HF) events. Cox proportional hazards regression was used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) for outcomes. RESULTS: There were 299 incident CVD, 188 CHD, and 151 HF events over 10.2 years. The lowest MCF quartile was associated with an increased risk for incident CVD [HR 2.42, CI: 1.58-3.72], CHD [HR 2.32, CI: 1.36-3.96] and HF events [HR 1.99, CI: 1.15-3.44]. In a model adjusted for demographics, CV risk factors, antihypertensive and lipid-lowering medication use, each standard deviation decrease in MCF was associated with incident CVD [HR 1.42, CI: 1.23-1.64], CHD [HR 1.40, CI: 1.17-1.67] and HF [HR 1.58, CI: 1.30-1.94]. In a subgroup analysis of participants with preserved ejection fraction and without left ventricular hypertrophy, the lowest MCF quartile and each standard deviation decrease in MCF was also associated with an increased risk for incident CVD in fully-adjusted analyses. CONCLUSIONS: MCF is a novel measure that can be measured using cMRI. In this multi-ethnic cohort, MCF is a measure that can be used to predict incident CVD events.
Authors: Mathew S Maurer; William J H Koh; Traci M Bartz; Sirish Vullaganti; Eddy Barasch; Julius M Gardin; John S Gottdiener; Bruce M Psaty; Jorge R Kizer Journal: Am J Cardiol Date: 2016-12-18 Impact factor: 2.778
Authors: Verônica R S Fernandes; Joseph F Polak; Thor Edvardsen; Benilton Carvalho; Antoinette Gomes; David A Bluemke; Khurram Nasir; Daniel H O'Leary; João A C Lima Journal: J Am Coll Cardiol Date: 2006-05-30 Impact factor: 24.094
Authors: M H Olsen; K Wachtell; J N Bella; V Palmieri; E Gerdts; G Smith; M S Nieminen; B Dahlöf; H Ibsen; R B Devereux Journal: J Hum Hypertens Date: 2004-06 Impact factor: 3.012
Authors: Monda L Shehata; Susan Cheng; Nael F Osman; David A Bluemke; João A C Lima Journal: J Cardiovasc Magn Reson Date: 2009-12-21 Impact factor: 5.364
Authors: Michel G Khouri; Ronald M Peshock; Colby R Ayers; James A de Lemos; Mark H Drazner Journal: Circ Cardiovasc Imaging Date: 2010-01-08 Impact factor: 7.792
Authors: Jorge R Kizer; Donna K Arnett; Jonathan N Bella; Mary Paranicas; D C Rao; Michael A Province; Albert Oberman; Dalane W Kitzman; Paul N Hopkins; Jennifer E Liu; Richard B Devereux Journal: Hypertension Date: 2004-05-03 Impact factor: 10.190
Authors: Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell Journal: Am J Cardiol Date: 2002-07-01 Impact factor: 2.778
Authors: Bharath Ambale-Venkatesh; Anderson C Armstrong; Chia-Ying Liu; Sirisha Donekal; Kihei Yoneyama; Colin O Wu; Antoinette S Gomes; Gregory W Hundley; David A Bluemke; Joao A Lima Journal: Eur Heart J Cardiovasc Imaging Date: 2013-10-20 Impact factor: 9.130
Authors: Julia Kozlitina; Sonia Garg; Mark H Drazner; Susan A Matulevicius; Colby Ayers; John Overton; Jeffrey Reid; Aris Baras; Krishnasree Rao; Ambarish Pandey; Jarett Berry; James A de Lemos; Justin L Grodin Journal: J Card Fail Date: 2021-10-09 Impact factor: 5.712
Authors: Patrick M Kozak; Min Pu; Katrina Swett; Martha L Daviglus; Mayank M Kansal; Daniela Sotres-Alvarez; Sonia G Ponce; Robert Kaplan; Mario Garcia; Carlos J Rodriguez Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2022-07-31